Abeona Therapeutics (ABEO) Shares Outstanding (2010 - 2026)

Abeona Therapeutics' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $56.9 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) rose 16.16% year-over-year to $56.9 million; the TTM figure through Mar 2026 stood at $56.9 million (up 16.16% YoY), while the FY2025 annual figure was $55.0 million, up 20.59% from the prior year.
• Shares Outstanding (Entity) for Q1 2026 stood at $56.9 million, up from $55.0 million in the prior quarter.
• The five-year high for Shares Outstanding (Entity) was $56.9 million in Q1 2026, with the low at $5.9 million in Q2 2022.
• The 5-year median for Shares Outstanding (Entity) is $27.6 million (2024), against an average of $31.5 million.
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) surged 265.87% in 2023, then advanced 16.16% in 2026.
• Abeona Therapeutics' Shares Outstanding (Entity) stood at $7.9 million in 2022, then soared by 171.96% to $21.4 million in 2023, then soared by 113.48% to $45.6 million in 2024, then rose by 20.59% to $55.0 million in 2025, then gained by 3.31% to $56.9 million in 2026.
• Business Quant data shows ABEO's Shares Outstanding (Entity) at $56.9 million in Q1 2026, $55.0 million in Q4 2025, and $52.4 million in Q3 2025.